{"id":754149,"date":"2023-05-03T07:20:58","date_gmt":"2023-05-03T11:20:58","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/adma-biologics-to-report-first-quarter-2023-financial-results-on-may-10-2023\/"},"modified":"2023-05-03T07:20:58","modified_gmt":"2023-05-03T11:20:58","slug":"adma-biologics-to-report-first-quarter-2023-financial-results-on-may-10-2023","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/adma-biologics-to-report-first-quarter-2023-financial-results-on-may-10-2023\/","title":{"rendered":"ADMA Biologics to Report First Quarter 2023 Financial Results on May 10, 2023"},"content":{"rendered":"<h2>\nConference Call Scheduled for May 10, 2023, at 4:30 p.m. ET<br \/>\n<\/h2>\n<div class=\"mw_release\">\n<p align=\"left\">RAMSEY, N.J. and BOCA RATON, Fla., May  03, 2023  (GLOBE NEWSWIRE) &#8212; ADMA Biologics, Inc. (Nasdaq: ADMA) (\u201cADMA\u201d or the \u201cCompany\u201d), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty plasma-derived biologics, today announced that it will report first quarter\u00a02023 financial results on May 10, 2023, after the U.S. financial markets close. ADMA\u2019s management team will host a live conference call and audio webcast on that date at 4:30 p.m. ET to discuss its financial results and other Company updates.<\/p>\n<p>To access the conference call, participants may register for the call <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=AfVk9Mk04DIfGoxwoqVcnyJ8Ql9WAh7R38GLoV0rQdUS5ca3FJqaoViIjzwKAX9Xxn7DlU1zIVG3GZvggZpbnRACmF4sPUZO8A8-xym4tCJUTdNM5bs4wyO1OsdtLAuuyu13HtQW_qdLXmD5-5Azdg==\" rel=\"nofollow noopener\" target=\"_blank\">here<\/a>\u00a0to receive the dial-in numbers and unique PIN to access the call seamlessly. It is recommended that you join 10 minutes prior to the event start (although you may register and dial in at any time during the call). A live audio webcast of the call will be available under \u201cEvents &amp; Webcasts\u201d in the investor section of the Company\u2019s website, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=a3qT2UvJYr8NTL72600Ul6pFTIFMIgK7huI7zQRC7Rn9NnhEakqaXbrJiVWuGsgAkI2mkSZV_79rFT1C6xl6-uc6qhRKi1joP7T0hho5pbIWGcxUC-j1uU4NJdJjdlG1_XyZwHMTTHuzRltnmTGISQ==\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/ir.admabiologics.com\/events-webcasts<\/a>. An archived webcast will be available on the Company\u2019s website approximately two hours after the event.<\/p>\n<p align=\"justify\">\n        <strong>About ADMA Biologics, Inc. (ADMA)<\/strong>\n      <\/p>\n<p align=\"justify\">ADMA Biologics is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. ADMA currently manufactures and markets three United States Food and Drug Administration (FDA)-approved plasma-derived biologics for the treatment of immune deficiencies and the prevention of certain infectious diseases: ASCENIV\u2122 (immune globulin intravenous, human \u2013 slra 10% liquid) for the treatment of primary humoral immunodeficiency (PI); BIVIGAM\u00ae (immune globulin intravenous, human) for the treatment of PI; and NABI-HB\u00ae (hepatitis B immune globulin, human) to provide enhanced immunity against the hepatitis B virus. ADMA manufactures its immune globulin products at its FDA-licensed plasma fractionation and purification facility located in Boca Raton, Florida. Through its ADMA BioCenters subsidiary, ADMA also operates as an FDA-approved source plasma collector in the U.S., which provides a portion of its blood plasma for the manufacture of its products. ADMA\u2019s mission is to manufacture, market and develop specialty plasma-derived, human immune globulins targeted to niche patient populations for the treatment and prevention of certain infectious diseases and management of immune compromised patient populations who suffer from an underlying immune deficiency, or who may be immune compromised for other medical reasons. ADMA has received U.S. Patents: 9,107,906, 9,714,283, 9,815,886, 9,969,793 and 10,259,865 and European Patent No. 3375789, among others, related to certain aspects of its products and product candidates. For more information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=KotspiPLQ8L4yvD7x8tFMev9MmiDHbLPe65bKzEW5HT6YhPaj6tvTQMCcAmgcV7_C-spcfFrLi00uBwZYb-d_RIFdH76ikA3g_1hR-45vVYSCeGnIZ1DuoDUHbRofWXYLOm9rCF7x7QkWOPDxhDGRk-HK-2pTRsN1kRw4KLFR2kGOI8TtdyqDDFppDBpxpNs3ocMJimK1q9eAu6tYcwpbm1dPkqXG1Pm02rr6Pqerudtk2cdaLS_zs39mc_QRDBaYsaGqiKlU5g4yFb_YXrk5g==\" rel=\"nofollow noopener\" target=\"_blank\"><u>www.admabiologics.com<\/u><\/a>.<\/p>\n<p align=\"justify\">\n        <strong>COMPANY CONTACT: <\/strong><br \/>\n        <br \/>Skyler Bloom<br \/>Senior Director, Business Development &amp; Corporate Strategy | 201-478-5552 |\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=gB1wEoRLzZrQN1PbRVM82O_lvJ320Ym0o-5PoJ-UT3u_HdhAHrNUrd_vZQ0-pNJwJArQk0nEu0fiPQ8aFdBuCr_qYwieGarVOxAAe7i2LP4=\" rel=\"nofollow noopener\" target=\"_blank\">sbloom@admabio.com<\/a><\/p>\n<p align=\"justify\">\n        <strong>INVESTOR RELATIONS CONTACT:<\/strong><br \/>\n        <br \/>Jason Finkelstein, MBA<br \/>Managing Director, Argot Partners | 212-600-1902 | <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=jnVu8WVFgt9up07N9YEuhwj8yIfb_fLVYd6TDcbdJQ2CfZM__AFYtM8zoEZ90A62BJDNtWMV2N4CUl8Gy4TZDnOg34rAvjZ00Ab7hqoZb3k=\" rel=\"nofollow noopener\" target=\"_blank\"><u>Jason@argotpartners.com<\/u><\/a><\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyOTMzOSM1NTYyMTgyIzIwMjM3MzA=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/NjliZjFiMGItMWE5My00MzViLTkxOGQtZmE0YjQyZDdjMjI4LTEwMzUyOTc=\/tiny\/ADMA-Biologics-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Conference Call Scheduled for May 10, 2023, at 4:30 p.m. ET RAMSEY, N.J. and BOCA RATON, Fla., May 03, 2023 (GLOBE NEWSWIRE) &#8212; ADMA Biologics, Inc. (Nasdaq: ADMA) (\u201cADMA\u201d or the \u201cCompany\u201d), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty plasma-derived biologics, today announced that it will report first quarter\u00a02023 financial results on May 10, 2023, after the U.S. financial markets close. ADMA\u2019s management team will host a live conference call and audio webcast on that date at 4:30 p.m. ET to discuss its financial results and other Company updates. To access the conference call, participants may register for the call here\u00a0to receive the dial-in numbers and unique PIN to access the call seamlessly. It is &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/adma-biologics-to-report-first-quarter-2023-financial-results-on-may-10-2023\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;ADMA Biologics to Report First Quarter 2023 Financial Results on May 10, 2023&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-754149","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ADMA Biologics to Report First Quarter 2023 Financial Results on May 10, 2023 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/adma-biologics-to-report-first-quarter-2023-financial-results-on-may-10-2023\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ADMA Biologics to Report First Quarter 2023 Financial Results on May 10, 2023 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Conference Call Scheduled for May 10, 2023, at 4:30 p.m. ET RAMSEY, N.J. and BOCA RATON, Fla., May 03, 2023 (GLOBE NEWSWIRE) &#8212; ADMA Biologics, Inc. (Nasdaq: ADMA) (\u201cADMA\u201d or the \u201cCompany\u201d), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty plasma-derived biologics, today announced that it will report first quarter\u00a02023 financial results on May 10, 2023, after the U.S. financial markets close. ADMA\u2019s management team will host a live conference call and audio webcast on that date at 4:30 p.m. ET to discuss its financial results and other Company updates. To access the conference call, participants may register for the call here\u00a0to receive the dial-in numbers and unique PIN to access the call seamlessly. It is &hellip; Continue reading &quot;ADMA Biologics to Report First Quarter 2023 Financial Results on May 10, 2023&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/adma-biologics-to-report-first-quarter-2023-financial-results-on-may-10-2023\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-05-03T11:20:58+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyOTMzOSM1NTYyMTgyIzIwMjM3MzA=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adma-biologics-to-report-first-quarter-2023-financial-results-on-may-10-2023\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adma-biologics-to-report-first-quarter-2023-financial-results-on-may-10-2023\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"ADMA Biologics to Report First Quarter 2023 Financial Results on May 10, 2023\",\"datePublished\":\"2023-05-03T11:20:58+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adma-biologics-to-report-first-quarter-2023-financial-results-on-may-10-2023\\\/\"},\"wordCount\":469,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adma-biologics-to-report-first-quarter-2023-financial-results-on-may-10-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgyOTMzOSM1NTYyMTgyIzIwMjM3MzA=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adma-biologics-to-report-first-quarter-2023-financial-results-on-may-10-2023\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adma-biologics-to-report-first-quarter-2023-financial-results-on-may-10-2023\\\/\",\"name\":\"ADMA Biologics to Report First Quarter 2023 Financial Results on May 10, 2023 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adma-biologics-to-report-first-quarter-2023-financial-results-on-may-10-2023\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adma-biologics-to-report-first-quarter-2023-financial-results-on-may-10-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgyOTMzOSM1NTYyMTgyIzIwMjM3MzA=\",\"datePublished\":\"2023-05-03T11:20:58+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adma-biologics-to-report-first-quarter-2023-financial-results-on-may-10-2023\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adma-biologics-to-report-first-quarter-2023-financial-results-on-may-10-2023\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adma-biologics-to-report-first-quarter-2023-financial-results-on-may-10-2023\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgyOTMzOSM1NTYyMTgyIzIwMjM3MzA=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgyOTMzOSM1NTYyMTgyIzIwMjM3MzA=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adma-biologics-to-report-first-quarter-2023-financial-results-on-may-10-2023\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ADMA Biologics to Report First Quarter 2023 Financial Results on May 10, 2023\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ADMA Biologics to Report First Quarter 2023 Financial Results on May 10, 2023 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/adma-biologics-to-report-first-quarter-2023-financial-results-on-may-10-2023\/","og_locale":"en_US","og_type":"article","og_title":"ADMA Biologics to Report First Quarter 2023 Financial Results on May 10, 2023 - Market Newsdesk","og_description":"Conference Call Scheduled for May 10, 2023, at 4:30 p.m. ET RAMSEY, N.J. and BOCA RATON, Fla., May 03, 2023 (GLOBE NEWSWIRE) &#8212; ADMA Biologics, Inc. (Nasdaq: ADMA) (\u201cADMA\u201d or the \u201cCompany\u201d), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty plasma-derived biologics, today announced that it will report first quarter\u00a02023 financial results on May 10, 2023, after the U.S. financial markets close. ADMA\u2019s management team will host a live conference call and audio webcast on that date at 4:30 p.m. ET to discuss its financial results and other Company updates. To access the conference call, participants may register for the call here\u00a0to receive the dial-in numbers and unique PIN to access the call seamlessly. It is &hellip; Continue reading \"ADMA Biologics to Report First Quarter 2023 Financial Results on May 10, 2023\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/adma-biologics-to-report-first-quarter-2023-financial-results-on-may-10-2023\/","og_site_name":"Market Newsdesk","article_published_time":"2023-05-03T11:20:58+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyOTMzOSM1NTYyMTgyIzIwMjM3MzA=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adma-biologics-to-report-first-quarter-2023-financial-results-on-may-10-2023\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adma-biologics-to-report-first-quarter-2023-financial-results-on-may-10-2023\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"ADMA Biologics to Report First Quarter 2023 Financial Results on May 10, 2023","datePublished":"2023-05-03T11:20:58+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adma-biologics-to-report-first-quarter-2023-financial-results-on-may-10-2023\/"},"wordCount":469,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adma-biologics-to-report-first-quarter-2023-financial-results-on-may-10-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyOTMzOSM1NTYyMTgyIzIwMjM3MzA=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adma-biologics-to-report-first-quarter-2023-financial-results-on-may-10-2023\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/adma-biologics-to-report-first-quarter-2023-financial-results-on-may-10-2023\/","name":"ADMA Biologics to Report First Quarter 2023 Financial Results on May 10, 2023 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adma-biologics-to-report-first-quarter-2023-financial-results-on-may-10-2023\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adma-biologics-to-report-first-quarter-2023-financial-results-on-may-10-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyOTMzOSM1NTYyMTgyIzIwMjM3MzA=","datePublished":"2023-05-03T11:20:58+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adma-biologics-to-report-first-quarter-2023-financial-results-on-may-10-2023\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/adma-biologics-to-report-first-quarter-2023-financial-results-on-may-10-2023\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adma-biologics-to-report-first-quarter-2023-financial-results-on-may-10-2023\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyOTMzOSM1NTYyMTgyIzIwMjM3MzA=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyOTMzOSM1NTYyMTgyIzIwMjM3MzA="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adma-biologics-to-report-first-quarter-2023-financial-results-on-may-10-2023\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"ADMA Biologics to Report First Quarter 2023 Financial Results on May 10, 2023"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/754149","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=754149"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/754149\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=754149"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=754149"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=754149"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}